Impact of donor-specific antibodies in reconstructive transplantation. (September 2013)

• Record Type: Journal Article
• Authors: Barone, Angelo A Leto; Sun, Zhaoli; Montgomery, Robert A; Lee, WP Andrew; Brandacher, Gerald
• Is Part Of: Expert review of clinical immunology. Volume 9:Number 9(2013)
• Page Start: 835
• Page End: 844
• Publication Date: 2013-09
• Subjects: antibody-mediated rejection -- chronic rejection -- desensitization -- donor-specific antibodies -- face transplantation -- hand transplantation -- kidney-paired donation -- plasmapheresis -- reconstructive transplantation -- vascularized composite allotransplantation; Clinical immunology -- Periodicals; 616.079
• DOI: 10.1586/1744666X.2013.824667
• Languages: English
• ISSNs: 1744-666X

Abstract

For many devastating injuries and tissue defects where conventional reconstruction is not possible, reconstructive transplantation such as hand and face transplantation has become a viable alternative. This novel approach allows for improved restoration of appearance, anatomy and function not feasible by other available treatment options. However, clinical management of these injuries prior to transplantation frequently requires multiple blood transfusion or skin grafts resulting in the formation of alloantibodies (anti-HLA IgG Abs) and a high degree of sensitization. The role of donor-specific antibodies (DSA) and mechanisms of antibody-mediated rejection (AMR) in reconstructive transplantation are still largely unknown. Thus there is an imminent need to develop a better understanding of the mechanisms related to DSA and AMR after reconstructive transplantation. In this review, we will define the role of DSA and mechanisms of AMR in reconstructive transplantation and compare them to established measures and treatment concepts in solid organ transplantation.